Nursing care in patients with contact isolation and carriers of multidrug resistant infections carriers of multidrug-resistant infections
DOI:
https://doi.org/10.35381/s.v.v6i2.2102Keywords:
Staphylococcus aureus, isolation & purification, Staphylococcal Infections. (Source, DeCS).Abstract
Objective: To elaborate a nursing care plan for patients of the "Hospital General Latacunga" in contact isolation, carriers of multidrug resistant infections. Methods: Descriptive observational study. The 53.33% responded that contact isolation is indicated for infections by multidrug-resistant bacteria, the highest incidence of isolated patients had the diagnosis of extrapulmonary tuberculosis. Conclusion: It was possible to identify the ausal agent of the infections and drug resistance by means of a culture of secretions where there was a higher incidence of tuberculosis followed by cellulitis, the most frequent causative agents being Staphylococcus aureus and Streptococcus pyogenes group A, with greater resistance to cephalosporins and aminoglycosides.
Downloads
References
González-Estrada A, Fernández-Prada M, Martínez Ortega C, Lana Pérez A, López González ML. Cumplimiento de las precauciones de aislamiento de contacto por microorganismos multirresistentes en un hospital de tercer nivel [Compliance with contact isolation precautions of multidrug-resistant microorganisms in a tertiary hospital]. Rev Calid Asist. 2016;31(5):293-299. doi:10.1016/j.cali.2016.01.003
Dhar S, Marchaim D, Tansek R, et al. Contact precautions: more is not necessarily better. Infect Control Hosp Epidemiol. 2014;35(3):213-221. doi:10.1086/675294
Manian FA, Ponzillo JJ. Compliance with routine use of gowns by healthcare workers (HCWs) and non-HCW visitors on entry into the rooms of patients under contact precautions. Infect Control Hosp Epidemiol. 2007;28(3):337-340. doi:10.1086/510811
de Toledo Piza FM, Marra AR, Silva M Jr, Sampaio Camargo TZ, de Oliveira Figueiredo RA, Edmond MB. Contact precautions in the intensive care unit setting: 12 years of surveillance. Am J Infect Control. 2013;41(4):371-372. doi:10.1016/j.ajic.2012.03.031
Dos Santos SLV, Martins MA, do Prado MA, Soriano JV, Bachion MM. Are there clinical signs and symptoms of infection to indicate the presence of multidrug-resistant bacteria in venous ulcers?. J Vasc Nurs. 2017;35(4):178-186. doi:10.1016/j.jvn.2017.08.001
van Dulm E, Tholen ATR, Pettersson A, et al. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands. PLoS One. 2019;14(9):e0222200. Published 2019 Sep 12. doi:10.1371/journal.pone.0222200
Landelle C, Pagani L, Harbarth S. Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens?. Virulence. 2013;4(2):163-171. doi:10.4161/viru.22641
Granzotto EM, Gouveia AM, Gasparetto J, Dantas LR, Tuon FF. Depression and anxiety in hospitalized patients on contact precautions for multidrug-resistant microorganisms. Infect Dis Health. 2020;25(3):133-139. doi:10.1016/j.idh.2020.01.002
Arriero GD, Taminato M, Kusahara DM, Fram D. Compliance to empirical contact precautions for multidrug-resistant microorganisms. Am J Infect Control. 2020;48(7):840-842. doi:10.1016/j.ajic.2019.10.004
Lucet JC, Decré D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29(6):1411-1418. doi:10.1086/313511
Lucet JC, Decré D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29(6):1411-1418. doi:10.1086/313511
Koch A, Mizrahi V. Mycobacterium tuberculosis. Trends Microbiol. 2018;26(6):555-556. doi:10.1016/j.tim.2018.02.012
Bañuls AL, Sanou A, Van Anh NT, Godreuil S. Mycobacterium tuberculosis: ecology and evolution of a human bacterium. J Med Microbiol. 2015;64(11):1261-1269. doi:10.1099/jmm.0.000171
Le Chevalier F, Cascioferro A, Majlessi L, Herrmann JL, Brosch R. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development. Future Microbiol. 2014;9(8):969-985. doi:10.2217/fmb.14.70
Dhar N, McKinney J, Manina G. Phenotypic Heterogeneity in Mycobacterium tuberculosis. Microbiol Spectr. 2016;4(6):10.1128/microbiolspec.TBTB2-0021-2016. doi:10.1128/microbiolspec.TBTB2-0021-2016
Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [published correction appears in Nature 1998 Nov 12;396(6707):190]. Nature. 1998;393(6685):537-544. doi:10.1038/31159
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
